[Pubmed] Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumors without myasthe

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 6512
Enregistré le : 31 mai 2020 09:57
6
Zodiaque :
Âge : 22
Contact :
    Linux Chrome

[Pubmed] Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumors without myasthe

Message par RSS-Bot »


Eur J Cardiothorac Surg. 2025 Apr 2:ezaf122. doi: 10.1093/ejcts/ezaf122. Online ahead of print.

ABSTRACT

BACKGROUND: Subxiphoid thoracoscopic surgery is an effective method for treating thymic tumors. We performed the first evaluation of the safety and feasibility of same-day discharge (SDD) in patients undergoing this procedure and summarized their associated clinical experience.

METHODS: We conducted a single-arm, single-center prospective clinical trial. This study was registered at www.chictr.org.cn (ChiCTR2300077148). The subjects were patients with a preoperative clinical diagnosis of thymic tumor. All eligible patients underwent examinations and preparations at the preoperative preparation center and subsequently underwent a subxiphoid thoracoscopic thymectomy. The evaluation indicators included R0 (complete resection without residual tumor) resection rate, SDD completion rate, 30-day postoperative readmission rate, number of emergency visits, perioperative complication rate, length of stay (LOS), and total medical costs.

RESULTS: A total of 39 patients were enrolled between November 2023 and April 2024. All patients underwent subxiphoid thoracoscopic resection of the thymic tumors to achieve R0 resection. The completion rate of the SDD surgery was 92.3% (36/39). The perioperative complication rate was 5.6% (2/36 patients). Only 2.8% (1/36) of the patients were readmitted within one month of an emergency visit due to pneumothorax. The median LOS was 11 hours (interquartile range (IQR): 10-14), and the median total medical cost was 19,400 RMB (IQR: 18,500-21,100).

CONCLUSION: The SDD procedure may be safe and feasible for selected patients undergoing subxiphoid thoracoscopic thymectomy, based on a small sample size. Large-scale studies are needed to confirm these preliminary findings.

PMID:40172929 | DOI:10.1093/ejcts/ezaf122


Source: https://pubmed.ncbi.nlm.nih.gov/4017292 ... t9+e462414
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »